HUM vs VVOS · P/E 39, rev $117.76B vs rev $15.0M
Humana Inc (HUM) versus Vivos Therapeutics Inc (VVOS) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Vivos Therapeutics Inc (VVOS) is a medical devices company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported VVOS revenue for 2024-12-31 was $15.0M. Net income was -$11.1M. Revenue was up 8.9% from 2023-12-31 to 2024-12-31. VVOS currently screens at market cap $7.1M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. VVOS currently screens at market cap $7.1M.
Not investment advice. Open the HUM and VVOS stock pages for the full models.
Not investment advice.